Psilocybin in Treatment-Resistant Depression
Author:
Affiliation:
1. From McLean Hospital, Belmont, and Harvard Medical School, Boston — both in Massachusetts.
Publisher
Massachusetts Medical Society
Subject
General Medicine
Link
http://www.nejm.org/doi/pdf/10.1056/NEJMe2210975
Reference12 articles.
1. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
2. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
3. LSD and the Drug Culture: New Evidence of Hazard
4. Untoward Reactions to Lysergic Acid Diethylamide (LSD) Resulting in Hospitalization
5. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fármacos enteógenos y la depresión resistente al tratamiento: Una revisión narrativa;Psicumex;2024-06-01
2. Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice;Journal of Psychopharmacology;2024-04-28
3. Psychedelic 5-HT2A receptor agonism: neuronal signatures and altered neurovascular coupling.;2023-10-13
4. Psychedelic 5-HT2Areceptor agonism: neuronal signatures and altered neurovascular coupling;2023-09-24
5. Role of Psychedelics in Treatment-Resistant Depression;Psychiatric Clinics of North America;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3